Interactive binding to the two principal ligand binding sites of human serum albumin: Effect of the neutral-to-base transition

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1432, Issue 2, 1999, Pages 313-323

  Yamasaki, Keishi ^a   Maruyama, Toru ^a   Yoshimoto, Kaori ^a   Tsutsumi, Yasuhiro ^a   Narazaki, Ryuichi ^a   Fukuhara, Akira ^a   Kragh Hansen, Ulrich ^b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Allosteric interaction; Displacement study; Human serum albumin; Ligand binding site; Neutral to base transition

Indexed keywords

ACENOCOUMAROL; ADIPIODONE; DIAZEPAM; HUMAN SERUM ALBUMIN; IBUPROFEN; PHENYLBUTAZONE;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG PROTEIN BINDING; EQUILIBRIUM DIALYSIS; FLUORESCENCE SPECTROSCOPY; LIGAND BINDING; PRIORITY JOURNAL;

ACRYLAMIDE; BINDING SITES; DANSYL COMPOUNDS; HUMANS; HYDROGEN-ION CONCENTRATION; LIGANDS; PROTEIN BINDING; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE;

EID: 0033045696     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(99)00098-9     Document Type: Article

References (31)

1. Dröge J.H.M., Wilting J., Janssen L.H.M. A comparative study of some physico-chemical properties of albumin samples from different sources - II. The characteristics of the N-B transition and the binding behavior with regard to warfarin and diazepam. Biochem. Pharmacol. 31:1982;3781-3786.
2. Peter T. Jr. Serum albumin. Adv. Protein Chem. 37:1985;161-245.
3. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33:1981;17-53.
4. Shaklai N., Garlick R.L., Bunn F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259:1984;3812-3817.
5. Leonard W.J. Jr., Vijai K.K., Foster J.F. A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotary dispersion studies. J. Biol. Chem. 283:1963;1984-1988.
6. Wilting J., van der Giesen W.F., Janssen L.H.M., Weideman M.M., Otagiri M., Perrin J.H. Effect of albumin conformation on the binding of warfarin to human serum albumin on the hydrogen, calcium and chloride ion concentrations as studied by circular dichroism, fluorescence and equilibrium dialysis. J. Biol. Chem. 255:1980;3032-3037.
7. Wilting J., Hart B.J., de Gier J.J. The role of albumin conformation in the binding of diazepam to human serum albumin. Biochim. Biophys. Acta. 626:1980;291-298.
8. Wanwimolruk S., Birkett D.J. The effects of N-B transition of human serum albumin on the specific drug binding sites. Biochim. Biophys. Acta. 709:1982;247-255.
9. Carter D.C., He J.X. Structure of serum albumin. Adv. Protein Chem. 45:1994;153-203.
10. Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5:1998;827-835.
11. McNamara P.J., Trueb V., Stoeckel K. Ceftriaxone binding to human serum albumin: indirect displacement by probenecid and diazepam. Biochem. Pharmacol. 40:1990;1247-1253.
12. Chen R.F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242:1966;173-181.
13. J.R. Lackowicz, Principles of Fluorescence Spectroscopy, Plenum Press, New York, 1983.
14. Eftink M.R., Ghiron C.A. Fluorescence quenching studies with proteins. Anal. Biochem. 114:1981;199-227.
15. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for micro-computer. J. Pharmacobiodyn. 4:1981;879-885.
16. Kragh-Hansen U. Relations between high-affinity binding sites of markers for binding regions on albumin. Biochem. J. 225:1985;629-638.
17. Reinhart G.D., Sharon S.B., Symcox M.M. Role of coupling entropy in establishing the nature and magnitude of allosteric response. Proc. Natl. Acad. Sci. USA. 86:1989;4032-4036.
18. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11:1975;824-832.
19. Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim. Biophys. Acta. 1295:1996;147-157.
20. M.R. Eftink, Fluorescence quenching reactions, in: T.G. Dewey (Ed.), Biophysical and Biochemical Aspects of Fluorescence Spectroscopy, Plenum Press, New York, 1991, pp. 1-41.
21. Yamasaki K., Miyoshi T., Maruyama T., Takadate A., Otagiri M. Characterization of region Ic in site I on human serum albumin: microenviromental analysis using fluorescence spectroscopy. Biol. Pharm. Bull. 17:1994;1656-1662.
22. Bos O.J.M., Labro J.F.A., Fischer M.J.E., Wilting J., Janssen L.H.M. The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin. J. Biol. Chem. 264:1989;953-959.
23. Hagag N.G., Birnbaum E.R., Darnall D.W. Distances between Tyr-411 and Trp-214 of human serum albumin measured by fluorescence energy transfer: effects of pH and fatty acids. Fed. Proc. 41:1982;1189.
24. De Meyts P., Roth J. Cooperativity in ligand binding: a new graphic analysis. Biochem. Biophys. Res. Commun. 66:1975;1118-1126.
25. von Hippel P.H., Bear D.G., Morgan W.D., McSwiggen J.A. Protein-nucleic acid interaction in transcription. Annu. Rev. Biochem. 53:1984;389-446.
26. 3H] acetate into platelet-activating factor. Arch. Biochem. Biophys. 257:1987;251-258.
27. Melsert R., Hoogerbrugge J.W., Rommerts F.F.G. Albumin, a biologically active protein acting on leydig cells. Mol. Cell. Endocrinol. 64:1989;35-44.
28. Fischer M.J., van Oosterhout A.J.M., Janssen L.M.H., Nijkamp F.P. Effect of albumin on adenylate cyclase receptor-related signal transduction of human peripheral blood mononuclear cells. Biochem. Pharmacol. 44:1992;351-358.
29. Wilting J., Kremer J.M.H., Izerman A.P., Schulman S.G. The kinetics of the binding of warfarin to human serum albumin as studied by stopped flow spectrophotometry. Biochim. Biophys. Acta. 706:1982;96-104.
30. Horie T., Mizuma T., Kasai S., Awazu S. Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am. J. Physiol. 254:1988;G465-G470.
31. Fischer M.J.E., Bos O.J.M., van der Linden R.F., Wilting J., Janssen L.H.M. Steroid binding to human serum albumin and fragments thereof. Role of protein conformation and fatty acid content. Biochem. Pharmacol. 45:1993;2411-2416.